KAYSEN DAVID B (President and CEO) purchased 2.0% of their position (1K shares) of PANBELA THERAPEUTICS, INC. on the open market
Open‑market purchases signal personal conviction — classified as a small addition.
P · 1 purchase
Filed: 6/14/2018ACC: 0001437749-18-011850
DirectorOfficer· President and CEO
Since May 2018
+2K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
2K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1K
Price / share
—
Trade value
—
% of position
2.0%
5/16/2018
50K→51K
Total
Net shares
+1K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2018 | P · Purchase | +1K | — | — | 2.0% | 50K | 51K |
| Total | +1K | $0.00 | ||||||
Derivative Transactions1
Warrant (right to buy)
Direct
Converts to
Common Stock
1K shares
Shares
+1K
Strike price
5
Held after
1K
Exercisable
—
5/16/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Common Stock1K shares | 5/16/2018 | P · Purchase | +1K | 5 | — | 1K |